Mr. Shay Shnet reports
NABIS HOLDINGS LAUNCHES BIS, A NEW CBD EXCLUSIVE BRAND
Nabis Holdings Inc.
has launched BIS (Be In Synergy), its new exclusive brand of cannabidiol (CBD) product lines. BIS was created with the mission to develop innovative, high-quality, efficient and safe consumer products through unique formulations and technologies that optimize the use and effects of cannabis. The BIS inaugural line of products is anticipated to be available for sale in late 2019.
The BIS brand includes a variety of exciting product lines to meet consumers' medical, lifestyle and wellness needs. The BIS launch will include SKUs for edibles, vapes, patches, cosmetics, skin care and hair products. In addition, BIS has exclusive rights in the United States for a state-of-the-art spray oral delivery system for various cannabis-based products, such as oils and liquids. This unique delivery system has an air and watertight design that will prolong shelf life and enhance product quality.
Of note, the BIS brand will launch the BIS sublingual films developed with Cannova, a provider of innovative solutions for cannabis consumption, that are designed to mask the taste of cannabinoids and increase solubility. Sublingual strips, which are consumed by under-the-tongue placement, allow for rapid absorption in which cannabinoids bypass the liver metabolism.
"Nabis has always been dedicated to the development and distribution of only the highest-quality products," said Shay Shnet, chief executive officer and director of Nabis. "Our creation of the BIS brand of CBD products reflect our commitment to excellence and consumer satisfaction. As we continue to expand the BIS brand, we are excited to present an elegant product line that we believe will fill a demand that has remained unmet in the cannabis and CBD industry until now."
BIS products will be available for purchase in the United States in-store at Nabis dispensary locations and on-line at the BIS e-commerce site,
anticipated to launch late 2019.
Nabis announces that further to its press release dated Jan. 29, 2019, its intention to acquire 100 per cent of the membership units of Organica Patient Group Inc., and RDF Management Group, and further to its press release dated Jan. 28, 2019, to invest in a 70-per-cent interest of Hivemind Refinery, has been terminated. Nabis intends to pursue other opportunities and is no longer proceeding with the transactions.
About Nabis Holdings Inc.
Nabis Holdings is a Canadian investment issuer that invests in high-quality cash-flowing assets across multiple industries, including real property, securities, cryptocurrency, and all aspects of the U.S. and international cannabis sector. Led by two of the co-founders of MPX Bioceutical, one of the largest takeovers in the U.S. cannabis space to date, the company has a proven record in emerging markets to create significant shareholder value. The company is focused on investing across the entire vertically integrated aspects of the space with a focus on revenue generation, EBITDA (earnings before interest, taxes, depreciation and amortization) and growth.
We seek Safe Harbor.
© 2020 Canjex Publishing Ltd. All rights reserved.